Factors Associated With Fear of Cancer Recurrence in a Multiethnic Cohort of Patients With Breast Cancer
Psycho-Oncology · 2025
DOI: 10.1002/pon.70307 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psycho-Oncology, 2025. Verfasst von Armaan Jamal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health Sciences, University of Chicago, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoplasm Recurrence, Local, Fear, Ethnicity. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Susan G. Komen, NCI NIH HHS, Breast Cancer Research Foundation.
Abstract (Originalsprache)
Background
Fear of cancer recurrence (FCR) is prevalent among patients with breast cancer, yet those at high risk are not well characterized.
Aims
This study aimed to identify the patient characteristics associated with FCR after diagnosis.
Methods
Between July and September 2023, participants in the Chicago Multiethnic Epidemiologic Breast Cancer Cohort completed the 9‐item FCR‐Short Form Inventory. A score of 22 or higher indicated clinically significant FCR (csFCR). Logistic and linear regression estimated associations between different risk factors and csFCR and FCR scores, respectively. Missing data were addressed using multiple imputation.
Results
Among 1390 stage I–III patients (mean age 63.1 years and 9.1 [mean] years since diagnosis), 262 (18.8%) reported csFCR. In adjusted models, csFCR was associated with having another cancer excluding non‐melanoma skin (adjusted odds ratio [aOR], 2.64; 95% CI, 1.66–4.21), greater levels of stress (aOR, 2.40 per 1‐SD increment; 95% CI, 1.98–2.91), having a prior recurrence (aOR, 2.26; 95% CI, 1.14–4.47), and having estrogen receptor‐positive tumors (aOR, 1.60; 95% CI, 1.06–2.40). Older age at diagnosis (aOR, 0.64 per 10‐year increment; 95% CI, 0.56–0.73) was associated with lower odds of csFCR. Similar associations were observed with continuous FCR scores, along with advanced stage at diagnosis associated with higher FCR scores ( p ‐trend = 0.001).
Conclusions
Nearly 1 in 5 breast cancer patients reported csFCR. Key risk factors included younger age at diagnosis, history of recurrence or other malignancies, greater levels of stress, and estrogen receptor‐positive breast cancer, which can inform targeted interventions to support survivorship.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Public Health Sciences, University of Chicago, Chicago, Illinois, USA.
- Cancer Prevention and Control Program, UChicago Medicine Comprehensive Cancer Center, Chicago, Illinois, USA.
- Center for Health and the Social Sciences, University of Chicago, Chicago, Illinois, USA.
- Section of Hematology & Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, USA.
- Center for Innovation in Global Health, University of Chicago, Chicago, Illinois, USA.
ORCID-Profile: Armaan Jamal, Jincong Q Freeman
Förderung
- Susan G. Komen
- NCI NIH HHS
- Breast Cancer Research Foundation
- NIA NIH HHS
- NIEHS NIH HHS
- National Cancer Institute
- National Institute on Aging
Zitieren
APA
Jamal, A., Zhao, F., Freeman, J. Q., Sun, Y., Tan, M. M., Nanda, R., Chen, N., Olopade, O. I., & Huo, D. (2025). Factors Associated With Fear of Cancer Recurrence in a Multiethnic Cohort of Patients With Breast Cancer. Psycho-Oncology. https://doi.org/10.1002/pon.70307
Vancouver
Jamal A, Zhao F, Freeman JQ, Sun Y, Tan MM, Nanda R, et al. Factors Associated With Fear of Cancer Recurrence in a Multiethnic Cohort of Patients With Breast Cancer. Psycho-Oncology. 2025. doi:10.1002/pon.70307
BibTeX
@article{Jamal2025,
author = {Jamal, Armaan and Zhao, Fangyuan and Freeman, Jincong Q and Sun, Yijia and Tan, Marcia M and Nanda, Rita and Chen, Nan and Olopade, Olufunmilayo I and Huo, Dezheng},
title = {Factors Associated With Fear of Cancer Recurrence in a Multiethnic Cohort of Patients With Breast Cancer},
journal = {Psycho-Oncology},
year = {2025},
doi = {10.1002/pon.70307}
}
EUVIMED